Patent · US Active

Anticancer agents of the anthracyclin family

US9475834B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 13, 2015
Grant dateOct 25, 2016
Priority date—
Expiry dateNov 13, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H15/252
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anthracyclin compounds of the general structure:are disclosed. In these compounds R1 is methyl, acetyl or hydroxyacetyl; R2—R5 and R10—R13 are independently H or methyl; R6 R7 and R8 are independently H, OH or OCH3; and n is zero or one. The compounds are useful for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.